ESTUTC-5 New YorkLog in Sign up

ALPMF
ASTELLAS PHARMA INC
stockOTC

EODNov 13, 2026

17.32USD+4.653%(+0.77)1,029

ALPMF News

Day breaks

04:23 PM ESTAstraZeneca gains additional bladder cancer indication for Imfinzi ·

Seeking Alpha

08:40 AM ESTAstellas, Immuneering Enter Pancreatic Cancer Trial Collaboration ·

RTTNews

08:01 PM ESTQ2 2027 Astellas Pharma Inc. Earnings Presentation Transcript ·

GuruFocus

02:57 AM ESTAstellas Pharma (ALPMY) Reports Strong H1 Results, Dividend Sustainability in Focus ·

GuruFocus

02:38 AM ESTAstellas Pharma ADR GAAP EPS of v134.47, revenue of ¥1270.86B; updates FY2027 outlook ·

Seeking Alpha

06:06 PM EDTPfizer Talzenna/Xtandi combo approved for earlier prostate cancer setting ·

Seeking Alpha

11:52 AM EDTKeytruda, Padcev combo for bladder cancer approved by European Commission ·

Seeking Alpha

08:00 AM EDTAI Proteins Announces Research Collaboration and License Agreement With Astellas Pharma to Discover and Develop Novel Miniprotein-Based Therapeutics Valued at Over $400 Million ·

Business Wire

09:09 AM EDTVir jumps on Gilead licensing deal worth up to $1.9B for cancer drugs ·

Seeking Alpha

10:31 AM EDTPompe Disease Market Set for Expansion During the Forecast Period (2026-2036) as Growth is Fueled by Next-Generation ERTs, Newborn Screening, and Pipeline Innovation | DelveInsight ·

PR Newswire

10:57 AM EDTHospital group files lawsuit to stop 340B rebate pilot again ·

Seeking Alpha

08:30 AM EDTVir Biotechnology Announces PSMA-targeted PRO-XTEN® Dual-masked T-cell Engager VIR-5500 Received FDA Fast Track Designation for the Treatment of Prostate Cancer ·

Business Wire

11:00 AM EDT50 new pitches found in hedge fund reports this week ·

Stock Analysis Compilation

07:30 PM EDTAstellas Highlights Data Advancing Cancer Care and Innovation for Patients with Hard-to-Treat Cancers at ESMO 2026 ·

PR Newswire

02:37 PM EDTAbbVie, Amgen, Pfizer, GSK among participants in new 340B rebate pilot ·

Seeking Alpha